North America ultra low freezers market is expected to reach USD 355.04 million by 2030 from USD 316.20 million in 2022, growing at a CAGR of 5.2% during the forecast period of 2023 to 2030. Market Segmentation North America Ultra Low Freezers Market, By Type (Product and Freezer Part and Accessories), Technology (Semi-Automated Freezers and Automated Freezers), Degree of Cooling (-41°C To -86° C Freezers, -87°C To -150° C Freezers, and -10°C To -40° C Freezers), Insulated Material (Polyurethane Foam, Vacuum Panel, and Others), Application (Organs, Blood & Blood Products, Biological Samples, Drug Compounds, and Others), End-User (Hospitals, Bio-Banks, Clinics, Corporate Laboratories, Pharmaceuticals, Academic and Research Institutes, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Third Party Distribution), Country (U.S., Canada and Mexico) - Industry Trends and Forecast to 2030 Overview of North America Ultra Low Freezers Market Dynamics Driver • Rising research and development activities in life sciences Restraint • Environmental concerns associated with ultra low freezers Opportunity • Increasing research in regenerative medicine Market Players Some of the key players operating in the North America ultra low freezers market are: • Thermo Fisher Scientific Inc. • Helmer Scientific Inc. • BINDER GmbH • Esco Micro Pte. Ltd. • NuAire, Inc. • LABCOLD • BioLife Solutions Inc. • PHC Corporation • REMI GROUP. • FUKUSHIMA GALILEI CO. LTD. • ARCTIKO • EVERMED s.r.l. • AticoExport • Vestfrost Solutions

1 INTRODUCTION 15 1.1 OBJECTIVES OF THE STUDY 15 1.2 MARKET DEFINITION 15 1.3 OVERVIEW OF THE NORTH AMERICA ULTRA LOW FREEZERS MARKET 15 1.4 LIMITATIONS 17 1.5 MARKETS COVERED 17 2 MARKET SEGMENTATION 20 2.1 MARKETS COVERED 20 2.2 GEOGRAPHICAL SCOPE 21 2.3 YEARS CONSIDERED FOR THE STUDY 22 2.4 CURRENCY AND PRICING 22 2.5 DBMR TRIPOD DATA VALIDATION MODEL 23 2.6 MULTIVARIATE MODELLING 26 2.7 PRODUCT SEGMENT LIFELINE CURVE 26 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 27 2.9 DBMR MARKET POSITION GRID 28 2.10 MARKET APPLICATION COVERAGE GRID 29 2.11 VENDOR SHARE ANALYSIS 30 2.12 SECONDARY SOURCES 31 2.13 ASSUMPTIONS 31 3 EXECUTIVE SUMMARY 32 4 PREMIUM INSIGHTS 35 4.1 PESTEL ANALYSIS 36 4.2 PORTER'S 5 FORCES 37 5 REGULATORY FRAMEWORK 38 6 MARKET OVERVIEW 40 6.1 DRIVERS 42 6.1.1 INCREASING DEMAND FOR BIOPHARMACEUTICALS AND VACCINES 42 6.1.2 RISING DEMAND FOR BLOOD AND BLOOD COMPONENTS 42 6.1.3 TECHNICAL ADVANCEMENTS IN ULTRA LOW FREEZER DESIGN 44 6.1.4 RISING R&D ACTIVITIES IN LIFE SCIENCES 45 6.2 RESTRAINTS 46 6.2.1 HIGH INSTALLATION AND OPERATIONAL COST OF ULTRA LOW FREEZERS 46 6.2.2 ENVIRONMENTAL CONCERNS ASSOCIATED WITH ULTRA LOW FREEZERS 47 6.3 OPPORTUNITIES 48 6.3.1 INCREASING DEMAND FOR BIOPRESERVATION AND BIOBANKING 48 6.3.2 INCREASING RESEARCH IN REGENERATIVE MEDICINE 49 6.4 CHALLENGES 50 6.4.1 TEMPERATURE VALIDATION AND CALIBRATION OF ULTRA LOW FREEZERS 50 6.4.2 DIFFICULTY IN MAINTENANCE AND REPAIRS OF ULTRA LOW FREEZERS 51 7 NORTH AMERICA ULTRA LOW FREEZERS MARKET, BY TYPE 52 7.1 OVERVIEW 53 7.2 PRODUCT 56 7.2.1 UPRIGHT ULTRA LOW TEMPERATURE FREEZER 56 7.2.2 CHEST ULTRA LOW TEMPERATURE FREEZER 56 7.2.3 BENCHTOP/UNDERCOUNTER ULTRA LOW TEMPERATURE FREEZER 57 7.2.4 OTHERS 57 7.3 FREEZER PARTS AND ACCESSORIES 57 8 NORTH AMERICA ULTRA LOW FREEZERS MARKET, BY TECHNOLOGY 58 8.1 OVERVIEW 59 8.2 AUTOMATED FREEZERS 62 8.3 SEMI-AUTOMATED FREEZERS 62 9 NORTH AMERICA ULTRA LOW FREEZERS MARKET, BY DEGREE OF COOLING 63 9.1 OVERVIEW 64 9.2 -41°C TO -86° C FREEZERS 67 9.3 -87°C TO -150° C FREEZERS 67 9.4 -10°C TO -40° C FREEZERS 67 10 NORTH AMERICA ULTRA LOW FREEZERS MARKET, BY INSULATED MATERIAL 69 10.1 OVERVIEW 70 10.2 POLYURETHANE FOAM 73 10.3 VACUUM PANELS 73 10.4 OTHERS 73 11 NORTH AMERICA ULTRA LOW FREEZERS MARKET, BY APPLICATION 75 11.1 OVERVIEW 76 11.2 BLOOD & BLOOD PRODUCTS 79 11.3 BIOLOGICAL SAMPLES 79 11.4 DRUG COMPOUNDS 80 11.5 ORGANS 80 11.6 OTHERS 81 12 NORTH AMERICA ULTRA LOW FREEZERS MARKET, BY END USER 82 12.1 OVERVIEW 83 12.2 HOSPITALS 86 12.2.1 LONG-TERM CARE HOSPITALS 86 12.2.2 ACUTE CARE HOSPITALS 86 12.2.3 NURSING FACILITIES 86 12.2.4 REHABILITATION CENTERS 87 12.3 CORPORATE LABORATORIES 87 12.4 PHARMACEUTICALS COMPANIES 87 12.5 BIO-BANKS 88 12.6 CLINICS 88 12.7 ACADEMIC AND RESEARCH INSTITUTES 89 12.8 OTHERS 89 13 NORTH AMERICA ULTRA LOW FREEZERS MARKET, BY DISTRIBUTION CHANNEL 90 13.1 OVERVIEW 91 13.2 DIRECT TENDERS 94 13.3 RETAIL SALES 94 13.4 THIRD PARTY DISTRIBUTORS 95 14 NORTH AMERICA ULTRA LOW FREEZER MARKET, BY REGION 96 14.1 NORTH AMERICA 96 14.1.1 US 99 14.1.2 CANADA 102 14.1.3 MEXICO 105 15 NORTH AMERICA ULTRA LOW FREEZERS MARKET, COMPANY LANDSCAPE 109 15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 109 16 SWOT ANALYSIS 110 17 COMPANY PROFILE 111 17.1 PHC CORPORATION 111 17.1.1 COMPANY SNAPSHOT 111 17.1.2 REVENUE ANALYSIS 111 17.1.3 COMPANY SHARE ANALYSIS 112 17.1.4 PRODUCT PORTFOLIO 112 17.1.5 RECENT DEVELOPMENT 112 17.2 EPPENDORF SE 113 17.2.1 COMPANY SNAPSHOT 113 17.2.2 COMPANY SHARE ANALYSIS 113 17.2.3 PRODUCT PORTFOLIO 114 17.2.4 RECENT DEVELOPMENT 114 17.3 THERMO FISHER SCIENTIFIC INC 115 17.3.1 COMPANY SNAPSHOT 115 17.3.2 REVENUE ANALYSIS 115 17.3.3 COMPANY SHARE ANALYSIS 116 17.3.4 PRODUCT PORTFOLIO 116 17.3.5 RECENT DEVELOPMENT 116 17.4 VWR INTERNATIONAL, LLC 117 17.4.1 COMPANY SNAPSHOT 117 17.4.2 COMPANY SHARE ANALYSIS 117 17.4.3 PRODUCT PORTFOLIO 118 17.4.4 RECENT DEVELOPMENT 118 17.5 BIOLIFE SOLUTIONS INC 119 17.5.1 COMPANY SNAPSHOT 119 17.5.2 REVENUE ANALYSIS 119 17.5.3 COMPANY SHARE ANALYSIS 120 17.5.4 PRODUCT PORTFOLIO 120 17.5.5 RECENT DEVELOPMENTS 120 17.6 ARCTIKO 121 17.6.1 COMPANY SNAPSHOT 121 17.6.2 PRODUCT PORTFOLIO 121 17.6.3 RECENT DEVELOPMENT 121 17.7 ATICOEXPORT 122 17.7.1 COMPANY SNAPSHOT 122 17.7.2 PRODUCT PORTFOLIO 122 17.7.3 RECENT DEVELOPMENT 122 17.8 B MEDICAL SYSTEMS 123 17.8.1 COMPANY SNAPSHOT 123 17.8.2 PRODUCT PORTFOLIO 123 17.8.3 RECENT DEVELOPMENT 123 17.9 BINDER GMBH 124 17.9.1 COMPANY SNAPSHOT 124 17.9.2 PRODUCT PORTFOLIO 124 17.9.3 RECENT DEVELOPMENT 124 17.10 BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD 125 17.10.1 COMPANY SNAPSHOT 125 17.10.2 PRODUCT PORTFOLIO 125 17.10.3 RECENT DEVELOPMENT 125 17.11 BIOWAY CORPORATION 126 17.11.1 COMPANY SNAPSHOT 126 17.11.2 PRODUCT PORTFOLIO 126 17.11.3 RECENT DEVELOPMENT 126 17.12 ESCO MICRO PTE. LTD 127 17.12.1 COMPANY SNAPSHOT 127 17.12.2 PRODUCT PORTFOLIO 127 17.12.3 RECENT DEVELOPMENT 127 17.13 EVERMED S.R.L 128 17.13.1 COMPANY SNAPSHOT 128 17.13.2 PRODUCT PORTFOLIO 128 17.13.3 RECENT DEVELOPMENT 128 17.14 FUKUSHIMA GALILEI CO. LTD 129 17.14.1 COMPANY SNAPSHOT 129 17.14.2 REVENUE ANALYSIS 129 17.14.3 PRODUCT PORTFOLIO 130 17.14.4 RECENT DEVELOPMENT 130 17.15 HELMER SCIENTIFIC INC 131 17.15.1 COMPANY SNAPSHOT 131 17.15.2 PRODUCT PORTFOLIO 131 17.15.3 RECENT DEVELOPMENTS 132 17.16 LABCOLD 133 17.16.1 COMPANY SNAPSHOT 133 17.16.2 PRODUCT PORTFOLIO 133 17.16.3 RECENT DEVELOPMENT 133 17.17 NUAIRE, INC 134 17.17.1 COMPANY SNAPSHOT 134 17.17.2 PRODUCT PORTFOLIO 134 17.17.3 RECENT DEVELOPMENT 135 17.18 REMI GROUP 136 17.18.1 COMPANY SNAPSHOT 136 17.18.2 REVENUE ANALYSIS 136 17.18.3 PRODUCT PORTFOLIO 137 17.18.4 RECENT DEVELOPMENT 137 17.19 TELSTAR 138 17.19.1 COMPANY SNAPSHOT 138 17.19.2 PRODUCT PORTFOLIO 138 17.19.3 RECENT DEVELOPMENT 138 17.20 VESTFROST SOLUTIONS 139 17.20.1 COMPANY SNAPSHOT 139 17.20.2 PRODUCT PORTFOLIO 139 17.20.3 RECENT DEVELOPMENT 139 18 QUESTIONNAIRE 140 19 RELATED REPORTS 143